CLA-2-30:RR:NC:2:238 D82810
Mr. Steve Shyne
Pfizer, Inc.
100 Jefferson Road
Parsippany, NJ 07054
RE: The tariff classification of VIAGRA (sildenafil citrate)
tablets from Ireland
Dear Mr. Shyne:
In your letter dated September 18, 1998, you requested a
tariff classification ruling.
The subject product, VIAGRA , is an oral therapy, in tablet
form, for erectile dysfunction. It contains the drug, sildenafil
citrate (CAS# 171599-83-0), as the active ingredient. New York
Ruling Letter B87488 noted.
The applicable subheading for the subject product will be
3004.90.9090, Harmonized Tariff Schedule of the United States
(HTS), which provides for: "[M]edicaments ... consisting of mixed
or unmixed products for therapeutic or prophylactic uses, put in
in measured doses or in forms or packings for retail sale: Other:
Other: Other: Other." The rate of duty will be free.
This merchandise may be subject to the requirements of the
Federal Food, Drug, and Cosmetic Act, which is administered by
the U.S. Food and Drug Administration. You may contact them at
5600 Fishers Lane, Rockville, Maryland 20857, telephone number
301-443-6553.
This ruling is being issued under the provisions of Part 177
of the Customs Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above
should be provided with the entry documents filed at the time
this merchandise is imported. If you have any questions
regarding the ruling, contact National Import Specialist Harvey
Kuperstein at 212-466-5770.
Sincerely,
Robert B. Swierupski
Director,
National Commodity
Specialist Division